Song Biotechnologies, LLC

01/31/2026

Just published a few days ago.

This mathematical model is, in part, based on recent work where we noticed different PO2 and VO2 in young vs old rats during muscle contraction.

Thank you to the team: Drs. Golub, Nugent, Pittman and Song

Mathematical models are essential for understanding oxygen transport and utilization during metabolic transitions. An electrical analogy concept proposed that exponential PO2 transients arise from in...

07/17/2025

This paper in SHOCK was accepted in February, and was available in pre-press, but this week the final version was uploaded.

This work compared a PEG-HBOC against autologous whole blood, fresh pooled plasma and Lactated Ringers'.

Thanks to the co-authors: Vandegriff, Sheppard, Malavalli and Nugent.

rs (HBOCs) are designed to relieve the hypoperfusion and hypoxia of shock during the critical pre-hospital period. A new PEGylated human HBOC product, VS-101, with high oxygen affinity and hyperoncotic pressure, has been designed for hypovolemic resuscitation protocols at the point of injury. Thirty...

05/05/2025

CTTACC 2025. Setup and ready for The conference. Proud to be part of this.

02/28/2025

A novel way of differentiating oxygen supply and demand in young vs old skeletal muscle.

Thank you to the collaborators Drs. Nugent, Golub and Pittman!

Muscle function declines with age. Since the primary energy source for contraction is aerobic, this study investigated age-related changes in muscle oxygenation dynamics to: characterize PO2 transien...

01/10/2025

Starting off the year with another peer-reviewed journal. Showcasing our interstitial oxygenation technique in various age groups.

Would like to thank Drs. Nugent, Golub and Pittman!

Human populations are experiencing unprecedented growth and longevity with lingering knowledge gaps of the characteristics, mechanisms, and pathologies of senescence. Invasive measurements and long-term control conditions for longitudinal studies are infeasible, necessitating the need for surrogate....

01/02/2025

This year marks the 10th anniversary of Song Biotechnologies.

We have been very fortunate to see continued growth despite shifts in the financial climate. To date, we have published over 15 peer-reviewed articles, successfully been part of over 10 BAA and SBIR grants, and have had the privilege of being part of the development and/or evaluation of exclusive novel technologies. These include potentially life-saving resuscitation fluids, transdermal drug delivery systems, devices that can detect pathogens non-invasively and drugs that will reduce systemic inflammation. With this momentum, we are excited to see what 2025 will bring.